Letrozole Suppresses the Fusion of Osteoclast Precursors through Inhibition of p38-Mediated DC-STAMP Pathway

Letrozole is a reversible nonsteroidal aromatase inhibitor that is widely used in postmenopausal breast cancer patients. It is well established that letrozole decreases bone density owing to estrogen depletion; however, few studies have reported its direct effect on bone cells in vitro. Therefore, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung Joon, Seong, Hwa-Sik, Choi, YunJeong, Heo, Soon Chul, Kim, Yong-Deok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664929/
https://www.ncbi.nlm.nih.gov/pubmed/33182361
http://dx.doi.org/10.3390/ijms21218396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664929/
https://www.ncbi.nlm.nih.gov/pubmed/33182361
http://dx.doi.org/10.3390/ijms21218396

Ejemplares similares